TOTAL PRO-JES
NDC 61657-0974, ADRENAL,BELLADONNA,CHELIDONIUM,DIOSCOREAVILLOSA,FOLLICULINUM,HYPOTHALAMUS,ARGININE,LILIumTIGRINIUM,LIVER,OOPHORINUM,PINEAL,PITUITARINUM,PLACENTANIUM,PROGESTERONE, liquid, from White Manufacturing Inc. BDA Micro-West.
- Product NDC
- 61657-0974
- Status
- Listed
- Labeler
- White Manufacturing Inc. BDA Micro-West
- Dosage form
- LIQUID
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Application
- —
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/61657-0974 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- PROGESTERONE6 [hp_C]/30mL
- EPINEPHRINE6 [hp_C]/30mL
- ATROPA BELLADONNA6 [hp_C]/30mL
- CHELIDONIUM MAJUS6 [hp_C]/30mL
- DIOSCOREA VILLOSA ROOT6 [hp_C]/30mL
- ESTRONE6 [hp_C]/30mL
- BOS TAURUS HYPOTHALAMUS6 [hp_C]/30mL
- ARGININE6 [hp_X]/30mL
- LILIUM LANCIFOLIUM FLOWERING TOP12 [hp_C]/30mL
- MAMMAL LIVER6 [hp_C]/30mL
- SUS SCROFA OVARY6 [hp_C]/30mL
- BOS TAURUS PINEAL GLAND6 [hp_X]/30mL
- BOS TAURUS PITUITARY GLAND6 [hp_X]/30mL
- SUS SCROFA PLACENTA6 [hp_X]/30mL
- PULSATILLA VULGARIS12 [hp_C]/30mL
- SEPIA OFFICINALIS JUICE12 [hp_C]/30mL
- SULFUR12 [hp_C]/30mL
Pharmacologic classes
Adrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Catecholamine [EPC]; Catecholamines [CS]; Progesterone [CS]; Progesterone [EPC]; alpha-Adrenergic Agonist [EPC]; beta-Adrenergic Agonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 61657-0974-1 | 61657097401 | 30 mL in 1 BOTTLE, DROPPER (61657-0974-1) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 61657-0974 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/61657-0974 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 61657-0974. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.